49LOW

BIO

BIOME AUST FPO [BIO]
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
Consumer Defensive · ASX Small Cap
$0.3450 +1.5%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical47
Catalyst51
Sentiment50
Fundamental96
Momentum61
Risk Gate50
Get alerts when BIO's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track BIO — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Cash positive / operating cashflow positive
  • Low P/S ratio (3.6x)
  • Strong revenue growth (+40%)
  • Piotroski F-Score strong (8/9, low-confidence approx)
  • Post-earnings drift: positive surprise (SUE +10)
  • Near 52-week low (2% of range)
  • Small-cap ($20-100M)
  • Capital raise activity (1 events)
  • CANSLIM C: Strong EPS growth (172% QoQ)
  • Strong return on equity (18%)
  • Sentiment is mixed — no strong consensus either way
  • Earnings are trending the right way — 2 consecutive improvements
  • Revenue growing at +40% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.14%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Overseas neutral (-1pts, S&P500 neutral, VIX 25)
Ask Scout AI about BIO
"What's driving BIO's score?" "How does BIO compare to peers?" "Key risks for BIO?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Secondary Trading Notice
NONE Application for quotation of securities - BIO
NONE Application for quotation of securities - BIO

Recent ASX Announcements

2026-03-19 Secondary Trading Notice
2026-03-19 Application for quotation of securities - BIO
2026-03-19 Application for quotation of securities - BIO
2026-03-18 Proposed issue of securities - BIO
2026-03-17 Secondary Trading Notice

Key Metrics

$78.3M
Market Cap
197K
Avg Volume
0.9x
Vol Ratio
$0.34 — $0.63
52-Week Range
0.2%
Short Interest
N/A
Cash Runway
18.1%
ROE
4.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSpassEPS Growth: 172%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 62%
LLeader vs LaggardlaggardRS: -4
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionneutralNeutral

Sector: Consumer Defensive

Ranked #19 of 46 · Sector avg: 48

View all Consumer Defensive signals →
Related Tickers
FRM 66CLV 58KME 58BXN 57GNC 55
Compare:BIO vs FRMBIO vs CLVBIO vs KME
Scout Pro — Deeper Analysis for BIO
Try Pro free for 30 days
Share this analysis

Track BIO and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required